oxonic acid has been researched along with Cardiomyopathy, Hypertrophic in 1 studies
Oxonic Acid: Antagonist of urate oxidase.
Cardiomyopathy, Hypertrophic: A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Watanabe, H | 1 |
| Itoh, H | 1 |
| Tsuchiya, Y | 1 |
| Miyagi, N | 1 |
| Sugiyama, T | 1 |
| Nakai, Y | 1 |
| Shinozaki, Y | 1 |
| Noguchi, T | 1 |
| Jinbu, Y | 1 |
| Kusama, M | 1 |
1 review available for oxonic acid and Cardiomyopathy, Hypertrophic
| Article | Year |
|---|---|
[Reinforcement of warfarin action in a patient administered S-1].
Topics: Aged; Anticoagulants; Antimetabolites, Antineoplastic; Cardiomyopathy, Hypertrophic; Cerebral Infarc | 2015 |